{
  "url": "https://openlegislation.uk/eu-regulation-2012-528/annex-IV/division-1/division-1.5",
  "json_url": "https://openlegislation.uk/eu-regulation-2012-528/annex-IV/division-1/division-1.5.json",
  "legislation": "eur/2012/528",
  "legislation_title": "Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2012-528",
  "path": "annex/IV/division/1/division/1.5",
  "kind": "division",
  "number": "1.5",
  "heading": "Grouping of substances and read-across approach",
  "text": "Substances whose physico-chemical, toxicological and ecotoxicological properties are similar or follow a regular pattern as a result of structural similarity may be considered as a group or ‘category’ of substances. Application of the group concept requires that physico-chemical properties, human and animal health effects, and environmental effects or environmental fate may be predicted from data for reference substance(s) within the group by interpolation to other substances in the group (read-across approach). This avoids the need to test every substance for every endpoint.\nThe similarities may be based on:\n(1)a common functional group indicating the presence of dangerous properties;\n(2)common precursors and/or the likelihood of common breakdown products via physical and biological processes, which result in structurally similar chemicals and indicates the presence of dangerous properties; or\n(3)a constant pattern in the changing of the potency of the properties across the category.\nIf the group concept is applied, substances shall be classified and labelled on this basis.\nIn all cases results shall:\nbe adequate for the purpose of classification and labelling and risk assessment,\nhave adequate and reliable coverage of the key parameters addressed in the corresponding test method, and\ncover an exposure duration comparable to or longer than the corresponding test method if exposure duration is a relevant parameter.\nIn all cases, adequate and reliable documentation of the applied method shall be provided.\n...",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Annex 4 para. 1.5 omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 142(c); 2020 c. 1, Sch. 5 para. 1(1)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2012/528/annex/IV/division/1/division/1.5",
    "retrieved_at": "2026-11-01T14:49:22.826342+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}